Unlock instant, AI-driven research and patent intelligence for your innovation.

Targeting molecule for reversing treatment drug resistance of anti-PD-1 antibody

A technology targeting molecules and drugs, applied in the fields of molecular immunology and tumor therapy

Active Publication Date: 2021-06-18
北京昭衍生物技术有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] At present, there is no Tim-3 antibody on the market at home and abroad, so the establishment and development of antibody-based detection and diagnosis and treatment supplies with independent intellectual property rights has important practical significance for the intervention of various related diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Targeting molecule for reversing treatment drug resistance of anti-PD-1 antibody
  • Targeting molecule for reversing treatment drug resistance of anti-PD-1 antibody
  • Targeting molecule for reversing treatment drug resistance of anti-PD-1 antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0092] Embodiment 1 Construction of anti-TIM-3 antibody expression vector

[0093] In the early stage, several antibodies with strong binding ability to TIM antigen were obtained through the screening of phage antibody library. This application is one of the antibodies, numbered 37#.

[0094] (1) Synthesize antibody heavy chain sequence (wherein, the heavy chain nucleic acid sequence of the 37# antibody is shown in SEQ ID NO: 19) and light chain sequence (wherein, the 37# antibody light chain nucleic acid sequence is shown in SEQ ID NO: :20), and it utilizes the molecular cloning method to clone the fragment into the ZY-CDMO carrier, and the ZY-CDMO carrier map is as follows figure 1 shown.

[0095] The specific operation is as follows: introduce an EcoRI restriction site at the 5' end of the light chain by conventional PCR, introduce an XbaI restriction site at the 3' end, and insert it between EcoRI and XbaI of the ZY-CDMO vector; A HindIII restriction site was introduced ...

Embodiment 2

[0096] Example 2 Expression and purification of anti-TIM-3 antibody

[0097] Inoculate 30ml in a 125ml cell culture shaker flask with a density of 0.5×10 6 cells / ml of CHO cells, when the cell density grows to 2×10 6 cells / ml or more, the cell viability is more than 95%, and the cells are 1×10 7 The cells / ml density was inoculated in the electrotransfer buffer, 40 μg plasmid was added to the electric shock cup, and then 0.7ml of cell suspension was added, and finally the electrotransfer buffer was added to 0.8ml, and mixed gently to avoid bubbles. Electric shock once under the conditions of 300V, 900μF, place the electric shock cup in the ice box for 5min, and dilute it into 6ml of culture medium at 37°C CO 2 After recovering in the incubator for 48 hours, add 75 μM MSX to the seed medium to inoculate the 96-well plate and perform clone screening, and divide the monoclonal cells into the 96-well plate by the limited dilution method, 37 ° C, 5% CO 2 Cultivate in an incubator...

Embodiment 3

[0099] Example 3 Anti-TIM-3 Antibody Affinity Activity Detection to TIM-3 Antigen

[0100] Use ELISA to detect affinity, the specific steps are as follows:

[0101] Coating: Take the ELISA plate and dilute the target protein human TIM-3 (Sino Biological, 10390-H08H) to 0.5 μg / ml with pH 9.6 coating solution, and coat 100 μl / well in a humid chamber overnight at 4°C.

[0102] Discard the liquid in the well, invert the plate and pat dry the residual liquid on a paper towel, add washing solution (0.1% PBST) 300 μl / well and wash 3 times.

[0103] Blocking: adding 300 μl / well of blocking solution (2% M-PBS) and standing at 37° C. for 1.0 h.

[0104] Discard the liquid in the well, invert the plate and pat dry the residual liquid on a paper towel, add washing solution (0.1% PBST) 300 μl / well and wash 3 times.

[0105] Add the primary antibody: Dilute the anti-TIM-3 antibody (37#, 67#, 75#) to 1mg / ml with DPBS, and then perform 10-fold dilutions in sequence, a total of 7 concentrati...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a targeting molecule for reversing treatment drug resistance of an anti-PD-1 antibody. The targeting molecule is a monoclonal antibody for blocking a TIM-3 function. The targeting molecule comprises a heavy chain and a light chain, wherein the amino acid sequence of a variable region of the heavy chain is as shown in SEQ ID NO.7, and the amino acid sequence of a variable region of the light chain is as shown in SEQ ID NO.8. The monoclonal antibody can be specifically combined with a TIM-3 antigen, can specifically block a TIM-3 mediated signal path, and can synergistically enhance the anti-immune disorder function of the anti-PD-1 antibody, so that the monoclonal antibody becomes a new drug for tumor immunotherapy and treatment of chronic virus infectious diseases and autoimmune diseases.

Description

technical field [0001] The invention belongs to the fields of tumor therapy and molecular immunology, and relates to a targeting molecule for reversing drug resistance of anti-PD-1 antibody therapy, in particular to a monoclonal antibody specifically binding to TIM-3. Background technique [0002] Tim-3 gene and Tim-3 structural protein: the mouse Tim-3 gene is located on chromosome 11, and the full-length transcript is 1015 bases; while the human Tim-3 gene is located on chromosome 5, and the transcript is complete The length is 1116 bases. The Tim family has at least four members, namely Tim-1, Tim-2, Tim-3, and Tim-4. Among them, Tim-1 is the receptor of hepatitis A virus, Tim-2 can be specifically expressed in Th2 cells, Tim-3 protein is the surface marker of activated Th1 cells, and Tim-4, as the ligand molecule of Tim-1, is expressed in Mature DC. [0003] Current data show that the mouse Tim-3 molecule is composed of 281 amino acids and is related to Th1-related re...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/28C12N15/13C12N15/85C12N5/10A61K39/395A61P35/00A61P29/00A61P19/02A61P25/00A61P1/00A61P37/02A61P3/10A61P37/06A61P31/00G01N33/68G01N33/577
CPCA61P1/00A61P3/10A61P19/02A61P25/00A61P29/00A61P31/00A61P35/00A61P37/02A61P37/06C07K16/2818C07K2317/51C07K2317/515C07K2317/56C07K2317/565C07K2317/76C07K2317/92C12N5/0682C12N15/85C12N2510/02C12N2800/107G01N33/577G01N33/68G01N2333/70521
Inventor 赵健郎小玲耿树生
Owner 北京昭衍生物技术有限公司